Allergies
are medical conditions caused primarily by hypersensitivity of the
immune system to some external stimulus. Allergy may cause
anaphylaxis—a medical condition that can cause irritation of the
skin, swelling of throat, shortness of breath, and in some cases,
death. Allergies are caused by various allergens such as pollen
grains, or certain foods such as peanuts. Vaccination is the process
of administering antigenic material or a vaccine to stimulate one’s
immune system to build up an adaptive immunity to pathogens.
Ask
for Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/121
Food
allergy is one of the major forms of allergies. Food allergies can be
caused by cow’s milk, eggs, shellfish, and many other foods,
including peanuts. However, peanut allergy is very prevalent in the
present scenario, especially in children. Therefore, peanut allergy
vaccine market is likely to gain significant traction in the near
future. Peanut allergy vaccine is administered to patients who are
detected with a probability of developing peanut allergy, so as to
prevent occurrences of allergy attacks such as anaphylaxis in the
future. According to a report published by National Centre for
Biotechnology Information, allergy to peanuts as well as tree nuts
(TNs) is the principal reason for fatal allergic reactions in the
U.S., and the occurrences appear to be rising. In this 11 year follow
up research, over 1% (around 3 million) people reported peanut or
tree nut allergies and the condition has been on the rise, mainly
amongst children. According to a report by Food Allergy Research and
Education (FARE), peanuts caused the most number of allergies in the
U.S., among all food allergens. Hence, peanut allergy vaccine market
has a major potential for growth in this region during the forecast
period (2018–2026).
Peanut
Allergy Vaccine Market Outlook – Increasing prevalence of peanut
allergy and lack of proper treatment
Globally,
incidence of peanut allergy is increasing supported by rising birth
rate. The risk of peanut allergy is more prevalent in countries such
as the U.K., Australia, and the U.S. According to American Academy of
Allergy Asthma & Immunology, 30.4% of the children with food
allergies suffered from multiple allergy attacks. Peanut allergy is
such an epidemic condition in the U.S. that the federal Food Allergen
Labeling and Consumer Protection Act (FALCPA) mandated that all
packaged food sold in the U.S. that include peanuts as an ingredient
have to prominently display the word 'Peanut' on the label. The only
solution to peanut allergy is restraining a patient from having
peanuts/peanuts containing products.
Key
Companies -
Companies
operating in the market in the current scenario are focusing on
obtaining approval for their products from the respective regulatory
bodies. The major companies operating in the market are Allergy
Therapeutics, Zicam, Aravax, Immunomic Therapeutic, Inc., Astellas,
and Aimmune.
Peanut
Allergy Vaccine Market Taxonomy
On
the basis of end user, the global peanut allergy vaccines market is
classified into:
Hospitals
Medical
Practitioners
Government
Agencies
Personal
Clinics
Others
For
More Information, Browse Full Report Here:
https://www.coherentmarketinsights.com/ongoing-insight/peanut-allergy-vaccine-market-121
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment